Feature Articles
8 of the Latest Solutions and Strategies to Improve Adherence
Each year, medication nonadherence costs the U.S. healthcare system hundreds of billions of dollars. ...
5 Essential Steps to Address Access Barriers Beyond Coverage
For years, payer strategies in the U.S. have had just one goal in mind: ...
The Unexpected Narrative of Breast Cancer Social Media Influencers
It is well-known in healthcare that doctors have increasingly less time to spend during ...
Why the Patient Voice Should Influence Drug Development—and How It Can
Big Tech companies have mastered the consumer experience, enabling the likes of Apple, Google, ...
Case Study: Scratching More Than Just the Surface
Chronic sinusitis (CS) with nasal polyps is a condition that often causes difficulty breathing ...
When it Comes to Lifecycle Management, Integrate, Don’t Ignore Uncertainty
While the COVID-19 pandemic has taught us that we cannot predict everything, we can ...
Kristie Kuhl Is Named Global Health Practice Leader at Finn Partners
Finn Partners, a global independent marketing and communications agency, has promoted Kristie Kuhl, JD, ...
A Vision to Redefine Social Health
Two companies—with one mission—unite to double down on patients as the future of social ...
Finn Partners Acquires Leading Health Technology Communications Firm Agency Ten22
Finn Partners, a global independent marketing and communications agency, has acquired Agency Ten22, a ...
Driving ROI in the Midst of a Cookiepocalypse
Over the past several years, the suffix “pocalypse” has been used for just about ...
Five Tips to Make the Most out of Virtual Medical Conferences
A recent article in Nature1 revealed that 74% of scientists think that conferences should ...
The Impact of Insights-Driven Engagement in Medical Affairs
Until very recently, functional operations for many Medical Affairs teams relied on legacy processes ...
Can Biogen’s Aduhelm Be Effective in Treatment of Alzheimer’s Despite the Controversy Surrounding its Approval?
When the FDA approved Biogen’s Aduhelm (aducanumab) in early June, it was the first ...